Evidence map›Paper›PMID 32892355›Full record

ArticleNeuropathology and applied neurobiology2020

Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.

D G Coughlin, R Ittyerah, C Peterson, J S Phillips, S Miller, K Rascovsky, D Weintraub, A D Siderowf, J E Duda, H I Hurtig and 7 more

Open access · greenAbstract read
In one paragraph

Article in Neuropathology and applied neurobiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Where do PDD and DLB SYNdromes fit in neuronal alpha-SYNuclein biological frameworks?Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  5. Primary age-related tauopathy.Acta neuropathologica · 2025
    Review
  6. Article
  7. Impact of hippocampal α-synuclein oligomers on cognitive trajectory in patients with dementia with Lewy bodies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Co-pathologies modify hippocampal protein accumulation patterns in neurodegenerative diseases.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

D G CoughlinPenn Digital Neuropathology Laboratory at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0003-4111-0102
R IttyerahDepartment of Radiology at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
C PetersonPenn Digital Neuropathology Laboratory at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
J S PhillipsPenn Digital Neuropathology Laboratory at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
S MillerPenn Digital Neuropathology Laboratory at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
K RascovskyDepartment of Neurology at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
D WeintraubDepartment of Neurology at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
A D SiderowfDepartment of Neurology at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
J E DudaDepartment of Neurology at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
H I HurtigDepartment of Neurology at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
D A WolkDepartment of Neurology at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
C T McMillanDepartment of Neurology at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
P A YushkevichDepartment of Radiology at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
M GrossmanDepartment of Neurology at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
E B LeeDepartment of Pathology at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
J Q TrojanowskiDepartment of Pathology at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
D J IrwinPenn Digital Neuropathology Laboratory at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0002-5599-5098
University of Pennsylvania · USPhiladelphia VA Medical Center · USUniversity of California System · US

Funding

UPenn ADCC Biomarker CoreP30AG010124 · NIA · UNIVERSITY OF PENNSYLVANIA · PI XIE, SHARON XIANGWEN · 1991 to 2020
$35.1M
UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Steven Dyal Edland · 2019 to 2026
$34.9M
Project IV: "Alpha-Synuclein Strains & Diverse Synucleinopathies"P50NS053488 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI TROJANOWSKI, JOHN Q. · 2007 to 2017
$20.9M
Project IV "Tackling Heterogeneity of Cognitive Trajectory in LBD"U19AG062418 · NIA · UNIVERSITY OF PENNSYLVANIA · PI TROJANOWSKI, JOHN Q. · 2019 to 2023
$18.1M
NRSA Training CoreTL1TR001880 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI MEAGHER, EMMA ANNE · 2016 to 2025
$10.0M
Spreading Tau Pathology in Non-Amnestic Alzheimer's DiseaseR01AG054519 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jeffrey S Phillips · 2018 to 2026
$7.4M
Identification of Endophenotypes in the Behavioral-Variant of Frontotemporal DemeK23NS088341 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI IRWIN, DAVID JOHN · 2014 to 2018
$836k
Multimodal Biomarkers in Frontotemporal Lobar DegenerationK01AG043503 · NIA · UNIVERSITY OF PENNSYLVANIA · PI MCMILLAN, COREY T · 2013 to 2017
$642k
A Network Neuroscience Investigation of Disease Spread in Non-Amnestic Mild Cognitive ImpairmentK01AG061277 · NIA · UNIVERSITY OF PENNSYLVANIA · PI PHILLIPS, JEFFREY S · 2019 to 2023
$583k
NCATS NIH HHS TL1 TR001880NIA NIH HHS K01 AG043503NIA NIH HHS K01 AG061277NIA NIH HHS P30 AG010124NIA NIH HHS P30 AG062429NIA NIH HHS R01 AG054519NIA NIH HHS U19 AG062418NINDS NIH HHS K23 NS088341NINDS NIH HHS P50 NS053488
6 · The paper itself

Abstract

aimsLewy body diseases (LBD) are characterized by alpha-synuclein (SYN) pathology, but comorbid Alzheimer's disease (AD) pathology is common and the relationship between these pathologies in microanatomic hippocampal subfields is understudied. Here we use digital histological methods to test the association between hippocampal SYN pathology and the distribution of tau and amyloid-beta (Aβ) pathology in LBD and contrast with AD subjects. We also correlate pathologic burden with antemortem episodic memory testing.

methodsHippocampal sections from 49 autopsy-confirmed LBD cases, 30 with no/low AD copathology (LBD - AD) and 19 with moderate/severe AD copathology (LBD + AD), and 30 AD patients were stained for SYN, tau, and Aβ. Sections underwent digital histological analysis of subfield pathological burden which was correlated with antemortem memory testing.

resultsLBD - AD and LBD + AD had similar severity and distribution of SYN pathology (P > 0.05), CA2/3 being the most affected subfield (P < 0.02). In LBD, SYN correlated with tau across subfields (R = 0.49, P < 0.001). Tau burden was higher in AD than LBD + AD (P < 0.001), CA1/subiculum and entorhinal cortex (ERC) being most affected regions (P = 0.04 to <0.01). However, tau pathology in LBD - AD was greatest in CA2/3, which was equivalent to LBD + AD. Aβ severity and distribution was similar between LBD + AD and AD. Total hippocampal tau and CA2/3 tau was inversely correlated with memory performance in LBD (R = -0.52, -0.69, P = 0.04, 0.009).

conclusionsOur findings suggest that tau burden in hippocampal subfields may map closely with the distribution of SYN pathology in subfield CA2/3 in LBD diverging from traditional AD and contribute to episodic memory dysfunction in LBD.

Indexed as

AgedAged, 80 and overalpha-SynucleinAlzheimer DiseaseAmyloid beta-PeptidesBrainEntorhinal CortexFemaleHippocampusHumansLewy Body DiseaseMaleParkinson Diseasetau Proteinsalpha-SynucleinAmyloid beta-Peptidestau ProteinsAlzheimer’s diseasehippocampusLewy body diseasesneuropathologysynucleintau

Identifiers

PMID32892355
PMCPMC7787184
OpenAlexW3083816987

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.